How has Esperion Therapeutics's available for sale investments changed year-over-year?

Esperion Therapeutics's available for sale investments increased by 40.4% year-over-year, from $88.46M to $124.21M.

What is the long-term trend for Esperion Therapeutics's available for sale investments?

Over 5 years (2020 to 2025), Esperion Therapeutics's available for sale investments has grown at a -13.6% compound annual growth rate (CAGR), from $281.78M to $135.64M.

Esperion Therapeutics ESPR Available for sale investments

Available for sale investments at other companies

AmgenAMGN

——

Regeneron PharmaceuticalsREGN

——

BridgeBio PharmaBBIO

——

Nektar TherapeuticsNKTR

——

BioCryst PharmaceuticalsBCRX

——

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's available for sale investments?: Esperion Therapeutics (ESPR) reported available for sale investments of $124.21M in Q1 2026.
How has Esperion Therapeutics's available for sale investments changed year-over-year?: Esperion Therapeutics's available for sale investments increased by 40.4% year-over-year, from $88.46M to $124.21M.
What is the long-term trend for Esperion Therapeutics's available for sale investments?: Over 5 years (2020 to 2025), Esperion Therapeutics's available for sale investments has grown at a -13.6% compound annual growth rate (CAGR), from $281.78M to $135.64M.